The prognostic value of aspartate beta-hydroxylase in early breast cancer

MLA

Barboro, Paola, et al. “The Prognostic Value of Aspartate Beta-Hydroxylase in Early Breast Cancer.” International Journal of Biological Markers, vol. 37, no. 3, Sept. 2022, pp. 328–35. EBSCOhost, https://doi.org/10.1177/03936155221108412.

APA

Barboro, P., Rubagotti, A., Poddine, S., Grillo, F., Mastracci, L., & Boccardo, F. (2022). The prognostic value of aspartate beta-hydroxylase in early breast cancer. International Journal of Biological Markers, 37(3), 328–335. https://doi.org/10.1177/03936155221108412

Chicago

Barboro, Paola, Alessandra Rubagotti, Silvia Poddine, Federica Grillo, Luca Mastracci, and Francesco Boccardo. 2022. “The Prognostic Value of Aspartate Beta-Hydroxylase in Early Breast Cancer.” International Journal of Biological Markers 37 (3): 328–35. doi:10.1177/03936155221108412.